Event Overview

Antibody-ligand traps unleash potent immune responses by binding and blocking proteins that typically enhance cancer progression and spread, such as TGFβ. In this webinar from The Scientist, LuZhe Sun will describe how he uses these traps to control the cell cycle in rapidly dividing cancer cells, shrinking tumors in the process.

Topics to be covered

Using novel TGFβ-targeting antibody-ligand traps to block tumor-promoting activities and enhance anti-cancer therapy

Friday, December 18, 2020

2:30 - 4:00 PM, Eastern Time

Speaker

LuZhe Sun, PhD
Professor and Dielmann Chair in Oncology
Department of Cell Systems and Anatomy
Associate Director for Basic Research, The Mays Cancer Center
University of Texas Health Science Center at San Antonio

Register Now

Blocking Cancer Progression and Shrinking Tumors with Antibody-ligand Traps

You must have Javascript and Cookies enabled to access this webcast.

Information you provide will be held in confidence and will be shared with the sponsoring vendor(s) of this webinar. The Scientist and sponsor(s) may use the information to contact you about your account and to let you know about related programs and products; you may opt-out at any time. This allows The Scientist to keep these webinars free of charge for our readers.

The Scientist c/o LabX Media Group
1000 N West Street, Suite 1200, Wilmington, Delaware, United States, 19801
Toll Free: 888.788.0328 | Phone: 705.528.6888
Email: privacy@the-scientist.com

Privacy Policy

The Scientist needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.